Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Acquired somatic MMR deficiency is a major cause of MSI tumor in patients suspected for “Lynch-like syndrome” including young patients

Abstract

Patients with tumors displaying high microsatellite instability (MSI-H) but no germline MMR inactivation are suspected for Lynch-like syndrome (LLS). To explore the involvement of acquired somatic MMR alteration as a cause, we screened 113 patient tumor samples for MMR gene variations and loss of heterozygosity. Somatic MMR alterations were found in 85.8% of patients including “double hits” in 63.7% of patients, mainly diagnosed with colon and endometrial cancers. Interestingly, 37.5% of them were under the age of 50, and seven patients were under 30. Somatic alterations were mainly attributed to the MLH1, MSH2 genes, likely reflecting the functional importance of these key MMR genes. Pathogenic variants co-existed in other cancer genes in particular the APC gene displaying a characteristic MMR deficiency-related “mutational signature”, indicating that it may be inactivated owing to MMR deficiency. We speculated that APC inactivation could trigger an accelerated malignant transformation underlying early-onset cancers. Our findings provide further insight into the mechanisms underlying LLS, somatic MMR inactivation being a major cause for early-onset LLS through pathways differing from those involved in late-onset sporadic cases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017; 2017:PO.17.00073.

  2. Carethers JM. Differentiating Lynch-like from Lynch syndrome. Gastroenterology. 2014;146:602–4.

    Article  Google Scholar 

  3. Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, Goossens M, Ouchene H, Hendriks-Cornelissen SJ, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumours. Gastroenterology. 2014;146:643–6.

    Article  CAS  Google Scholar 

  4. Geurts-Giele WR, Leenen CH, Dubbink HJ, Meijssen IC, Post E, Sleddens HF, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers. J Pathol. 2014;234:548–59.

    Article  CAS  Google Scholar 

  5. Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology. 2014;147:1308–16.

    Article  Google Scholar 

  6. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, et al. APC mutations in colorectal tumours with mismatch repair deficiency. Proc Natl Acad Sci USA. 1996;93:9049–54.

    Article  CAS  Google Scholar 

  7. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De RY, Li YJ, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA. 1997;94:12122–7.

    Article  CAS  Google Scholar 

  8. Morak M, Heidenreich B, Keller G, Hampel H, Laner A, de la Chapelle A, et al. Biallelic MUTYH mutations can mimic Lynch syndrome. Eur J Hum Genet. 2014;22:1334–7.

    Article  CAS  Google Scholar 

  9. Jansen AM, Van WT, van den Akker BE, Ventayol GM, Ruano D, Tops CM, et al. Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers. Eur J Hum Genet. 2016;24:1089–92.

    Article  CAS  Google Scholar 

  10. Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304–10.

    Article  CAS  Google Scholar 

  11. Sourrouille I, Coulet F, Lefevre JH, Colas C, Eyries M, Svrcek M, et al. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumours. Fam Cancer. 2013;12:27–33.

    Article  CAS  Google Scholar 

  12. Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, et al. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort. BMJ. 2016;6:e010293.

    Google Scholar 

  13. Joly MO, Attignon V, Saurin JC, Desseigne F, Leroux D, Martin-Denavit T, et al. Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients. Hum Mutat. 2015;36:292–5.

    Article  CAS  Google Scholar 

  14. Kadyrov FA, Dzantiev L, Constantin N, Modrich P. Endonucleolytic function of MutLalpha in human mismatch repair. Cell. 2006;126:297–308.

    Article  CAS  Google Scholar 

  15. Ten Broeke SW, van der Klift HM, Tops CMJ, Aretz S, Bernstein I, Buchanan DD, et al. Cancer risks for PMS2-associated Lynch Syndrome. J Clin Oncol. 2018;36:2961–8.

    Article  Google Scholar 

  16. Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell. 1990;61:759–67.

    Article  CAS  Google Scholar 

  17. Schell MJ, Yang M, Teer JK, Lo FY, Madan A, Coppola D, et al. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nat Commun. 2016;7:11743.

    Article  CAS  Google Scholar 

  18. The cancer Genome Atlas. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.

    Article  Google Scholar 

  19. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, et al. Somatic mutations of the APC gene in colorectal tumours: mutation cluster region in the APC gene. Hum Mol Genet. 1992;1:229–33.

    Article  CAS  Google Scholar 

  20. Helleday T, Eshtad S, Nik-Zainal S. Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet. 2014;15:585–98.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Drs. E. Barouk-Simonet, B. Buecher, MN. Bonnet-Dupeyron, O. Caron, C. Corsini, F. Desseigne, M. Dhooge, S. Fert Ferrer, S. Giraud, M. Lebrun, D. Leroux, JM. Limacher, A. Lortholary, D. Malka, T. Martin-Denavit, S. Olschwang, F. Prieur, JC. Saurin, and their genetic counseling assistants for case collection and for providing clinical information. We thank Drs. O. Cabaret, C. Ferraro-Peyret, L. Golmard, C. Maugard for tumor sampling and DNA preparation. And we thank Mrs. Brigitte Manship for manuscript editing assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qing Wang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lefol, C., Sohier, E., Baudet, C. et al. Acquired somatic MMR deficiency is a major cause of MSI tumor in patients suspected for “Lynch-like syndrome” including young patients. Eur J Hum Genet 29, 482–488 (2021). https://doi.org/10.1038/s41431-020-00778-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41431-020-00778-6

This article is cited by

Search

Quick links